Watch drug discovery experts at DDW Turning Science into Business Symposium
The on-demand version of the DDW Turning Science into Business Symposium is available to watch now!
The event, which took place at The Francis Crick Institute on 4 November, features talks covering aspects of drug discovery including AI, oncology, CRISPR, neuroscience and more.
It also includes a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process.
You will hear presentations from:
- Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge
- Nikhil Gupta, Principal Scientist, Cancer Research Horizons – AstraZeneca Functional Genomics Centre
- Lawrence Welch, Inside Sales Specialist, Nuclera
- Chas Bountra, Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University
- Dr Cathy Tralau-Stewart, Executive Director, The Milner Therapeutics Institute, University of Cambridge
- Professor Emma Mead, Chief Scientific Officer, Alzheimer’s Research UK, Oxford Drug Discovery Institute
The panel discussion featured:
- Joanne Taylor, SVP Research, Gain Therapeutics
- Nadine Clemo, VP Global Program Leader, Apollo Therapeutics
- Dr Cathy Tralau-Stewart, Executive Director, The Milner Therapeutics Institute, University of Cambridge
The event was sponsored by Nuclera (lead sponsor), Collaborative Drug Discovery (coffee break sponsor) and Thermo Fisher Scientific (sponsor).
The on-demand version of the DDW Turning Science into Business Symposium is only available for a limited time! Register now to watch before December 24th!
